Klinische Studien gesponsert von Agennix

Insgesamt 20 ergebnisse

    • NCT01273779
      Suspendiert
      Bedingungen: Severe Sepsis
    • NCT01168882
      Zurückgezogen
      Bedingungen: Hematological Malignancies
    • NCT00854633
      Unbekannter Status
      Bedingungen: Nosocomial Infections
    • NCT00707304
      Abgeschlossen
      Bedingungen: Non Small Cell Lung Cancer
    • NCT00706862
      Unbekannter Status
      Bedingungen: Non Small Cell Lung Cancer
    • NCT00630656
      Abgeschlossen
      Bedingungen: Severe Sepsis
    • NCT00480623
      Beendet
      Bedingungen: Prostate Cancer
    • NCT00450970
      Beendet
      Bedingungen: Prostate Cancer
    • NCT00370383
      Abgeschlossen
      Bedingungen: Lung Cancer
    • NCT00329329
      Beendet
      Bedingungen: Malignancies
    • NCT00313456
      Beendet
      Bedingungen: Tumors; Prostate Cancer
    • NCT00268970
      Abgeschlossen
      Bedingungen: Non-small Cell Lung Cancer
    • NCT00265655
      Abgeschlossen
      Bedingungen: Metastatic Breast Cancer
    • NCT00125411
      Beendet
      Bedingungen: Tumors
    • NCT00095186
      Abgeschlossen
      Bedingungen: Carcinoma, Renal Cell
    • NCT00093132
      Beendet
      Bedingungen: Carcinoma, Non-small Cell Lung; Lung Cancer
    • NCT00069745
      Abgeschlossen
      Bedingungen: Prostate Cancer; Hormone Refractory Prostate Cancer
    • NCT00473720
      Abgeschlossen
      Bedingungen: Advanced Cancers
    • NCT01220284
      Unbekannter Status
      Bedingungen: Advanced Solid Tumors
    • NCT01528137
      Beendet
      Bedingungen: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma; Recurrent Metastatic Squamous Neck Cancer With Occult Primary; Recurrent Salivary Gland Cancer; Recurrent Squamous Cell Carcinoma of the Hypopharynx; Recurrent Squamous Cell Carcinoma of the Larynx; Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity; Recurrent Squamous Cell Carcinoma of the Nasopharynx; Recurrent Squamous Cell Carcinoma of the Oropharynx; Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Recurrent Verrucous Carcinoma of the Larynx; Recurrent Verrucous Carcinoma of the Oral Cavity; Salivary Gland Squamous Cell Carcinoma; Stage III Salivary Gland Cancer; Stage III Squamous Cell Carcinoma of the Hypopharynx; Stage III Squamous Cell Carcinoma of the Larynx; Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage III Squamous Cell Carcinoma of the Nasopharynx; Stage III Squamous Cell Carcinoma of the Oropharynx; Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage III Verrucous Carcinoma of the Larynx; Stage III Verrucous Carcinoma of the Oral Cavity; Stage IV Non-small Cell Lung Cancer; Stage IV Squamous Cell Carcinoma of the Hypopharynx; Stage IV Squamous Cell Carcinoma of the Nasopharynx; Stage IVA Salivary Gland Cancer; Stage IVA Squamous Cell Carcinoma of the Larynx; Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IVA Squamous Cell Carcinoma of the Oropharynx; Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage IVA Verrucous Carcinoma of the Larynx; Stage IVA Verrucous Carcinoma of the Oral Cavity; Stage IVB Salivary Gland Cancer; Stage IVB Squamous Cell Carcinoma of the Larynx; Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IVB Squamous Cell Carcinoma of the Oropharynx; Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage IVB Verrucous Carcinoma of the Larynx; Stage IVB Verrucous Carcinoma of the Oral Cavity; Stage IVC Salivary Gland Cancer; Stage IVC Squamous Cell Carcinoma of the Larynx; Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IVC Squamous Cell Carcinoma of the Oropharynx; Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage IVC Verrucous Carcinoma of the Larynx; Stage IVC Verrucous Carcinoma of the Oral Cavity; Tongue Cancer